HQL / Abrdn Life Sciences Investors - Insider Trading and Ownership Report - SEC Form 3, 4, 5

艾伯登生命科學投資者
US ˙ NYSE ˙ US87911K1007

內部人士股份3,068,629 shares
所有內部人士16
內部人士情緒分數

「內部人士情緒分數」用於查找被公司內部人士購入的公司。

它是一個複雜的多因素量化模型的結果,該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例,以及內部人士擁有的總股份的指標。該分數的範圍從0到100,數值越高表示相對於同行業而言具有更高程度的內部人士持股水平,50為平均值。

更新頻率:每日

查閱「內部人士首選」,該清單呈現被內部人士購入最多的公司。

高管情緒分數

「高管情緒分數」用於查找被公司管理層購入的公司。

根據定義,公司高管是公司內部人士,但與其他內部人士(10%的股東和董事會成員)不同,公司高管每天在公司工作,而且他們使用自己的資金進行交易。(10%的股東和董事會成員通常是基金經理,管理著其他人的資金。)因此,公司高管進行的內幕交易更為重要性,應該被適當地重視和關注。

如同「內部人士情緒分數」,「高管情緒分數」也是一個複雜的多因素量化模型的計算結果,該模型能夠辨識具有最高高管累積持有水平的公司。

更新頻率:每日

查閱「內部人士首選」,該清單呈現被內部人士購入最多的公司。

關鍵內部人士指標

此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。

舉例來說,一般認為內部人士的買入是一個積極的指標,因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少(甚至有內部人士賣出)的公司。

內部人士買入淨數(排名)

0 ( )
685 out of 10948

內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示(範圍從0到100%)。

內部人士買入佔流通股比例(排名)

0.000% ( )
688 out of 10786

內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數,除以總流通股數並乘以100。

內幕交易圖表

以下圖表顯示了Abrdn Life Sciences Investors內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。

內部人員名單及盈利指標

這張表格顯示已知的內部人員名單,從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外,我們還提供了最新披露的持股信息。此外,我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊,請查看YouTube網絡研討會

See our leaderboard of most profitable insider traders.

內部人士 平均收益(%) 持股
數量
分拆
調整
Michael W Bonney Director - [D] 2,388 2,388
Jeffrey Allen Bailey Director - [D] 580 580
Rose DiMartino Director - [D] 1,000 1,000
Kathleen Goetz Director - [D] 1,085 1,085
Thomas M Kent Director - [D] 1,300 1,300
內部人士 平均收益(%) 持股
數量
分拆
調整
Bill Maher Director - [D] 1,715 1,715
Elizabeth G Nabel Director - [D] 5,574 5,574
Rebecca Suzanne Nichols - 0 0
Daniel R Omstead President, Director - [D] [O] 197,518 197,518
Oleg M Pohotsky Director - [D] 305 305
內部人士 平均收益(%) 持股
數量
分拆
調整
Christian Pittard Director - [D] 7,923 7,923
William S Reardon Director - [D] 1,612 1,612
Uwe E Reinhardt Director - [D] 3,010 3,010
Todd Reit Director - [D] 1,000 1,000
Lucinda H Stebbins Director - [D] 5,985 5,985
Saba Capital Management, L.P. 10% Owner - [10%] 2,837,633 2,837,633

Report errors via our new Insider Auditing Tool

追蹤內部人士買入記錄 - 短期收益分析

在這一部分,我們分析了在 HQL / Abrdn Life Sciences Investors 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況, 結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 內部人士 報告
股數
報告
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2025-12-16 Pittard Christian 7,923 16.8818 7,923 16.8818 133,755 141 18.2200 10,603 7.93
2024-08-23 Maher Bill 650 15.3700 650 15.3700 9,990
2024-07-16 DiMartino Rose 1,000 15.5300 1,000 15.5300 15,530
2024-06-26 Saba Capital Management, L.P. 100 14.0700 100 14.0700 1,407
2024-06-24 Saba Capital Management, L.P. 13,812 14.0800 13,812 14.0800 194,473
2024-06-13 Saba Capital Management, L.P. 8,467 13.8200 8,467 13.8200 117,014
2024-06-12 Saba Capital Management, L.P. 2,400 13.8800 2,400 13.8800 33,312
2024-06-11 Saba Capital Management, L.P. 2,039 13.7600 2,039 13.7600 28,057
2024-06-10 Saba Capital Management, L.P. 9,704 13.7100 9,704 13.7100 133,042

經調整價格 已按拆股調整。 經調整股數 已按拆股調整。

HQL / Abrdn Life Sciences Investors Insider Trades
追蹤內部人士賣出記錄 - 短期虧損分析

在這一部分,我們分析了在 HQL / Abrdn Life Sciences Investors 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況, 結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 內部人士 報告
股數
報告
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2025-09-22 Saba Capital Management, L.P. 41,623 14.1400 41,623 14.1400 588,549 1 14.1100 -1,248 -0.21
2025-09-19 Saba Capital Management, L.P. 6,989 14.1000 6,989 14.1000 98,545
2025-09-18 Saba Capital Management, L.P. 40,208 14.0700 40,208 14.0700 565,727
2025-09-17 Saba Capital Management, L.P. 24,328 13.9900 24,328 13.9900 340,349
2025-09-16 Saba Capital Management, L.P. 2,026 13.9900 2,026 13.9900 28,344
2025-09-15 Saba Capital Management, L.P. 700 14.1300 700 14.1300 9,891
2025-09-11 Saba Capital Management, L.P. 15,116 14.2800 15,116 14.2800 215,856
2025-09-02 Saba Capital Management, L.P. 14,083 14.0400 14,083 14.0400 197,725
2025-08-29 Saba Capital Management, L.P. 23,723 13.8900 23,723 13.8900 329,512

經調整價格 已按拆股調整。 經調整股數 已按拆股調整。

HQL / Abrdn Life Sciences Investors Insider Trades
交易歷史

點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易,將在標記為 10b-5 的欄位中顯示 X。

呈報
日期
交易
日期
表格 內部人士 證券代碼 證券種類 代碼 10b5-1 直接 行使
價格
單位
價格
股數
變化
價值
變化 (1K)
剩餘
期權
剩餘
股份
2025-12-18 2025-12-16 4 Pittard Christian HQL Common Stock P - Purchase D 16.8818 7,923 134 7,923
2025-09-23 2025-09-22 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14.1400 -41,623 -589 2,837,633
2025-09-23 2025-09-19 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14.1000 -6,989 -99 2,879,256
2025-09-19 2025-09-18 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14.0700 -40,208 -566 2,886,245
2025-09-19 2025-09-17 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13.9900 -24,328 -340 2,926,453
2025-09-17 2025-09-16 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13.9900 -2,026 -28 2,950,781
2025-09-17 2025-09-15 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14.1300 -700 -10 2,952,807
2025-09-15 2025-09-11 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14.2800 -15,116 -216 2,953,507
2025-09-04 2025-09-02 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14.0400 -14,083 -198 2,968,623
2025-09-02 2025-08-29 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13.8900 -23,723 -330 2,982,706
2025-08-27 2025-08-26 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13.8300 -400 -6 3,006,429
2025-08-25 2025-08-21 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14.0700 -10,710 -151 3,006,829
2025-05-22 2025-05-20 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12.7100 -11,419 -145 3,017,539
2025-05-19 2025-05-15 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12.0800 -23,729 -287 3,028,958
2025-05-15 2025-05-14 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12.0400 -600 -7 3,052,687
2025-05-15 2025-05-13 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12.2800 -730 -9 3,053,287
2025-05-12 2025-05-08 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 11.9800 -12,689 -152 3,054,017
2025-05-08 2025-05-07 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12.1900 -1,366 -17 3,066,706
2025-04-21 2025-04-17 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 11.7800 -9,144 -108 3,068,072
2025-04-17 2025-04-15 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 11.9200 -1,700 -20 3,077,216
2025-04-15 2025-04-14 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 11.6700 -15,400 -180 3,078,916
2025-04-14 2025-04-10 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 11.1400 -30,156 -336 3,094,316
2025-04-07 2025-04-04 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 11.5700 -6,889 -80 3,124,472
2025-04-07 2025-04-03 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12.2300 -10,321 -126 3,131,361
2025-04-03 2025-04-02 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12.2800 -29,102 -357 3,141,682
2025-04-03 2025-04-01 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12.4500 -17,621 -219 3,170,784
2025-04-01 2025-03-31 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12.5800 -48,623 -612 3,188,405
2025-03-31 2025-03-28 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12.9500 -3,602 -47 3,237,028
2025-03-31 2025-03-27 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13.0100 -32,922 -428 3,240,630
2025-03-25 2025-03-24 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13.2100 -2,329 -31 3,273,552
2025-02-27 2025-02-26 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13.6200 -200 -3 3,275,881
2025-02-18 2025-02-13 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13.8800 -100 -1 3,276,081
2025-02-13 2025-02-12 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13.7500 -36,536 -502 3,276,181
2025-02-12 2025-02-11 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13.7700 -19,756 -272 3,312,717
2025-02-12 2025-02-10 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13.9500 -42,987 -600 3,332,473
2025-02-05 2025-02-04 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14.0500 -4,065 -57 3,375,460
2025-02-05 2025-02-03 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14.0300 -1,846 -26 3,379,525
2025-02-03 2025-01-31 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14.2700 -15,143 -216 3,381,371
2025-02-03 2025-01-30 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14.1600 -21,835 -309 3,396,514
2025-01-30 2025-01-29 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14.1200 -11,674 -165 3,418,349
2024-08-27 2024-08-23 4 Maher Bill By Spouse HQL Common Stock P - Purchase I 15.3700 650 10 1,715
2024-07-18 2024-07-16 4 DiMartino Rose HQL Common Stock P - Purchase D 15.5300 1,000 16 1,000
2024-06-27 2024-06-26 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 14.0700 100 1 3,429,991
2024-06-25 2024-06-24 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 14.0800 13,812 194 3,429,891
2024-06-18 3 Nichols Rebecca Suzanne HQL Common Shares D 0
2024-06-14 2024-06-13 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.8200 8,467 117 3,416,079
2024-06-14 2024-06-12 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.8800 2,400 33 3,407,612
2024-06-11 2024-06-11 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.7600 2,039 28 3,405,212
2024-06-11 2024-06-10 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.7100 9,704 133 3,403,173
2024-06-10 2024-06-07 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.7200 3,763 52 3,393,469
2024-06-10 2024-06-06 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.8000 9,598 132 3,389,706
2024-06-05 2024-06-05 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.7600 26,083 359 3,380,108
2024-06-05 2024-06-04 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.5000 33,357 450 3,354,025
2024-06-03 2024-05-31 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.2900 21,369 284 3,320,668
2024-05-31 2024-05-30 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.0500 669 9 3,299,299
2024-05-31 2024-05-29 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.0900 38,033 498 3,298,630
2024-05-31 2024-05-28 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.3800 8,714 117 3,260,597
2024-05-23 2024-05-23 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.5000 1,303 18 3,251,883
2024-05-17 2024-05-15 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 14.1900 34,755 493 3,250,580
2024-05-14 2024-05-10 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.8600 57,862 802 3,215,825
2024-05-10 2024-05-09 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.8000 17,373 240 3,157,963
2024-05-10 2024-05-08 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.7000 10,986 151 3,140,590
2024-05-07 2024-05-07 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.7600 50,161 690 3,129,604
2024-05-07 2024-05-06 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.6200 10,713 146 3,079,443
2024-05-02 2024-05-02 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.4600 26,274 354 3,068,730
2024-05-02 2024-05-01 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.0200 252 3 3,042,456
2024-05-01 2024-04-30 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.1300 16,573 218 3,042,204
2024-04-29 2024-04-26 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.0000 120,304 1,564 3,025,602
2024-04-26 2024-04-25 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 12.9900 97,574 1,267 2,905,298
2024-04-26 2024-04-24 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.1200 20,529 269 2,807,724
2024-04-23 2024-04-23 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13.1500 48,203 634 2,787,195
2024-04-23 2024-04-22 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 12.8800 2,022 26 2,738,992
2024-04-22 2024-04-19 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 12.8400 42,459 545 2,736,970
2024-04-22 2024-04-18 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 12.8000 81,738 1,046 2,694,511
2024-04-19 3 Saba Capital Management, L.P. - HQL Common Stock I 2,694,511
2024-04-12 2024-04-09 4 Goetz Kathleen HQL Common Stock P - Purchase D 13.3183 400 5 1,085
2024-01-04 2024-01-02 4 Reit Todd HQL Common Stock P - Purchase D 13.7980 1,000 14 1,000
2024-01-02 2023-12-28 4 Maher Bill HQL Common Stock P - Purchase D 13.5700 1,000 14 1,000
2023-09-25 2023-09-25 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 12.3926 10,096 125 197,518
2023-09-20 2023-09-20 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 12.6838 12,000 152 187,422
2022-03-24 2022-03-23 4 Goetz Kathleen HQL Shares of Beneficial Interest P - Purchase D 16.2700 92 2 685
2022-01-27 2022-01-26 4 Goetz Kathleen HQL Shares of Beneficial Interest P - Purchase D 17.5441 593 10 593
2021-08-12 2021-08-11 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 21.6300 6,403 138 146,489
2020-10-26 2020-10-26 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 17.5229 6,175 108 131,836
2020-10-21 2020-10-21 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 17.7489 5,950 106 125,661
2020-09-23 2020-09-22 4 Bailey Jeffrey Allen HQL Shares of Beneficial Interest P - Purchase D 17.2800 580 10 580
2020-05-22 2020-05-21 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 17.7406 5,950 106 114,821
2020-03-17 2020-03-17 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 13.2659 8,300 110 105,814
2018-12-19 3 NABEL ELIZABETH G HQL Shares of Beneficial Interest D 5,574
2018-12-19 3 NABEL ELIZABETH G HQL Shares of Beneficial Interest D 5,574
2018-12-19 3 NABEL ELIZABETH G HQL Shares of Beneficial Interest D 5,574
2018-01-29 2018-01-25 4 Kent Thomas M HQL Shares of Beneficial Interest P - Purchase D 21.0369 1,300 27 1,300
2015-06-29 2015-06-29 4 STEBBINS LUCINDA H HQL Shares of Beneficial Interest P - Purchase D 28.1700 -1,000 -28 5,985
2014-07-11 2014-06-24 4 REINHARDT UWE E HQL Subscription Rights X - Other D 19.75 -2,256 0
2014-07-11 2014-06-24 4 REINHARDT UWE E HQL Shares of Beneficial Interest X - Other D 19.7500 752 15 3,010
2014-07-01 2014-06-24 4 OMSTEAD DANIEL R HQL Subscription Rights X - Other D 19.75 -44,064 0
2014-07-01 2014-06-24 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest X - Other D 19.7500 14,688 290 58,757
2014-07-01 2014-06-30 4 REARDON WILLIAM S HQL Shares of Beneficial Interest P - Purchase D 19.7500 200 4 1,612
2014-06-30 2014-06-24 4 BONNEY MICHAEL W HQL Subscription Rights X - Other D 19.75 -2,077 0
2014-06-30 2014-06-24 4 BONNEY MICHAEL W HQL Shares of Beneficial Interest X - Other D 19.7500 1,459 29 2,388
2014-06-30 2014-06-24 4 POHOTSKY OLEG M HQL Subscription Rights X - Other D 19.75 -228 0
2014-06-30 2014-06-24 4 POHOTSKY OLEG M HQL Shares of Beneficial Interest X - Other D 19.7500 76 2 305
2014-06-30 2014-06-24 4 REARDON WILLIAM S HQL Subscription Rights X - Other D 19.75 -1,134 0
2014-06-30 2014-06-24 4 REARDON WILLIAM S HQL Shares of Beneficial Interest X - Other D 19.7500 578 11 1,412
2014-06-30 2014-06-24 4 STEBBINS LUCINDA H HQL Subscription Rights X - Other D 19.75 -3,000 0
2014-06-30 2014-06-24 4 STEBBINS LUCINDA H HQL Shares of Beneficial Interest X - Other D 19.7500 1,000 20 6,985
2013-06-04 2013-06-04 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 17.5789 6,000 105 40,980
2012-03-21 2012-03-19 4 POHOTSKY OLEG M HQL Shares of beneficial interest P - Purchase D 13.2999 200 3 200
2012-03-12 2012-03-09 4 BONNEY MICHAEL W HQL Shares of Beneficial Interest P - Purchase D 13.2546 800 11 800
2012-03-12 2012-03-09 4 REARDON WILLIAM S HQL Shares of Beneficial Interest P - Purchase D 13.2660 772 10 772
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista